UTMD Earnings
Latest Revenue8.5M
Latest Net Income2.7M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.84 | 8.5M | 2.7M | -14.3% | -10.6% |
| Q1 2026 | $0.82 | 8.7M | 2.6M | -10.2% | -10.9% |
| Q4 2025 | $0.80 | 9.0M | 2.6M | -1.2% | -7.0% |
| Q3 2025 | $0.82 | 9.8M | 2.6M | -1.9% | -19.6% |
| Q2 2025 | $0.94 | 10.0M | 3.0M | -4.3% | -4.1% |
| Q1 2025 | $0.92 | 9.7M | 3.0M | -14.4% | -15.6% |
| Q4 2024 | $0.86 | 9.2M | 2.9M | -25.7% | -27.1% |
| Q3 2024 | $1.02 | 10.0M | 3.6M | -20.0% | -5.6% |
| Q2 2024 | $0.98 | 10.4M | 3.5M | — | — |
| Q1 2024 | $1.09 | 11.3M | 4.0M | — | — |
| Q4 2023 | $1.18 | 12.3M | 4.3M | — | — |
| Q3 2023 | $1.08 | 12.5M | 3.9M | — | — |
Utah Medical Products (UTMD) — Earnings